|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0000894,
umls-concept:C0027051,
umls-concept:C0034975,
umls-concept:C0040044,
umls-concept:C0087111,
umls-concept:C0205225,
umls-concept:C0439609,
umls-concept:C0522523,
umls-concept:C0680207,
umls-concept:C0702240,
umls-concept:C1274040,
umls-concept:C1522318,
umls-concept:C1707455,
umls-concept:C1947933,
umls-concept:C1948027,
umls-concept:C1948041,
umls-concept:C2698650
|
|
pubmed:issue |
5
|
|
pubmed:dateCreated |
2009-5-25
|
|
pubmed:abstractText |
We sought to evaluate the impact of a strategy of reduced-dose fibrinolytic acceleration of ST-segment elevation myocardial infarction (STEMI) treatment followed by urgent percutaneous coronary intervention (FAST-PCI) on the mortality, reinfarction, and stroke rates in STEMI patients as compared with a primary percutaneous coronary intervention (PPCI) approach.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Oct
|
|
pubmed:issn |
1876-7605
|
|
pubmed:author |
pubmed-author:AhnChulC,
pubmed-author:AndersonH VernonHV,
pubmed-author:AtharHarisH,
pubmed-author:ChanRoger SRS,
pubmed-author:DenktasAli EAE,
pubmed-author:HenryTimothy DTD,
pubmed-author:LarsonDavid MDM,
pubmed-author:McKayRaymond GRG,
pubmed-author:NilesNathaniel WNW,
pubmed-author:SchulerGerhardG,
pubmed-author:SdringolaStefanoS,
pubmed-author:SimonsMichaelM,
pubmed-author:SmallingRichard WRW,
pubmed-author:ThieleHolgerH
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
1
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
504-10
|
|
pubmed:dateRevised |
2010-11-18
|
|
pubmed:meshHeading |
pubmed-meshheading:19463352-Aged,
pubmed-meshheading:19463352-Angioplasty, Balloon, Coronary,
pubmed-meshheading:19463352-Combined Modality Therapy,
pubmed-meshheading:19463352-Coronary Circulation,
pubmed-meshheading:19463352-Emergency Medical Services,
pubmed-meshheading:19463352-Female,
pubmed-meshheading:19463352-Fibrinolytic Agents,
pubmed-meshheading:19463352-Humans,
pubmed-meshheading:19463352-Logistic Models,
pubmed-meshheading:19463352-Male,
pubmed-meshheading:19463352-Middle Aged,
pubmed-meshheading:19463352-Multivariate Analysis,
pubmed-meshheading:19463352-Myocardial Infarction,
pubmed-meshheading:19463352-Recurrence,
pubmed-meshheading:19463352-Registries,
pubmed-meshheading:19463352-Risk Assessment,
pubmed-meshheading:19463352-Risk Factors,
pubmed-meshheading:19463352-Stroke,
pubmed-meshheading:19463352-Thrombolytic Therapy,
pubmed-meshheading:19463352-Time Factors,
pubmed-meshheading:19463352-Treatment Outcome,
pubmed-meshheading:19463352-United States,
pubmed-meshheading:19463352-Vascular Patency
|
|
pubmed:year |
2008
|
|
pubmed:articleTitle |
Reduced-dose fibrinolytic acceleration of ST-segment elevation myocardial infarction treatment coupled with urgent percutaneous coronary intervention compared to primary percutaneous coronary intervention alone results of the AMICO (Alliance for Myocardial Infarction Care Optimization) Registry.
|
|
pubmed:affiliation |
University of Texas Medical School and Memorial Hermann Heart and Vascular Institute, Houston, USA. Ali.E.Denktas@uth.tmc.edu
|
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Research Support, Non-U.S. Gov't,
Multicenter Study
|
